Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Eur Acad Dermatol Venereol ; 18(4): 416-21, 2004 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-15196153

RESUMEN

OBJECTIVES: Retinoic acid (RA) has long been used, both topically and systemically, for disorders of keratinization, acne and related disorders. In the present study, the efficacy and tolerability of topical RA prepared as a cyclodextrin beta complex (beta-CD) is investigated in 66 acne vulgaris patients. METHODS: This randomized, double-blind, placebo-controlled study compares nightly topical application of RA/beta-CD complex hydrogel formulation (0.025%), RA/beta-CD complex in moisturizing base (0.025%), hydrogel base, moisturizer base or a commercial RA gel (0.05%) in acne vulgaris patients. Improvement of acne was assessed using a 5-point improvement scale and by measuring sebum and moisture content of the skin using an SM 810 sebumeter/corneometer. RESULTS: After 3 months of treatment, mean scores of acne improvement on the 5-point scale were 4 with the RA/beta-CD complex hydrogel formulation, 4.1 with the RA/beta-CD complex in moisturizing base, 1.2 with hydrogel placebo base, 1.1 with moisturizer placebo base and 3 with the commercial RA product. All patients treated with the commercial product experienced local side-effects. One patient discontinued due to severe irritation. None of the patients treated with the RA/beta-CD complex in the moisturizing base and hydrogel formulation experienced significant local irritation, although the sebum content of the skin decreased after application of the RA/beta-CD preparations. This change was not significant compared to controls. The moisture content of the skin was better preserved in the group treated with the RA/beta-CD complex in the moisturizing base. CONCLUSION: The topical RA/beta-CD complex, in hydrogel and moisturizing base, was more effective than the twice concentrated commercial RA product. There were few topical side-effects with this new formulation, which increases patient compliance. Topical RA/beta-CD (0.025% RA) did not significantly reduce sebum secretion but may help to preserve optimum epidermal moisture content with the proper base formulation. This is the first study in the literature reporting efficacy and tolerability of the topical RA/beta-CD complex in acne vulgaris. We conclude that the topical RA/beta-CD complex displays an improved efficacy and tolerability profile and is an effective treatment alternative for acne vulgaris.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Ciclodextrinas/administración & dosificación , Queratolíticos/efectos adversos , Tretinoina/administración & dosificación , Administración Tópica , Adolescente , Adulto , Método Doble Ciego , Combinación de Medicamentos , Femenino , Geles , Humanos , Hidrogeles , Queratolíticos/administración & dosificación , Masculino , Tretinoina/efectos adversos
2.
J Eur Acad Dermatol Venereol ; 16(2): 152-3, 2002 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-12046820

RESUMEN

Pemphigus vulgaris is an autoimmune blistering disorder in which both genetic and environmental factors, mainly drugs, are thought to play a part in its aetiopathogenesis. Although some drugs that contain thiol groups, such as D-penicillamine and captopril, and non-thiol drugs, such as cephalosporin, have been reported to trigger or induce pemphigus, there are no previous reports regarding the influence of quinolones in triggering this disease. Here we present a case of pemphigus possibly triggered by quinolones.


Asunto(s)
Ciprofloxacina/efectos adversos , Pénfigo/inducido químicamente , Quinolonas/efectos adversos , Infecciones Urinarias/tratamiento farmacológico , Anciano , Azatioprina/administración & dosificación , Biopsia con Aguja , Ciprofloxacina/uso terapéutico , Quimioterapia Combinada , Estudios de Seguimiento , Humanos , Masculino , Mucosa Bucal/patología , Pénfigo/tratamiento farmacológico , Pénfigo/patología , Prednisolona/administración & dosificación , Quinolonas/uso terapéutico , Medición de Riesgo , Índice de Severidad de la Enfermedad , Resultado del Tratamiento , Infecciones Urinarias/diagnóstico
3.
Clin Exp Dermatol ; 23(5): 208-10, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10233602

RESUMEN

Stasis dermatitis is a cutaneous finding associated with chronic venous failure resulting in venous stasis. Arteriovenous fistula in the hand may cause a chronic venous stasis. We report a case of stasis dermatitis of the hand associated with an iatrogenic arteriovenous fistula. Stasis dermatitis should be considered as a potential complication of iatrogenic arteriovenous fistula.


Asunto(s)
Fístula Arteriovenosa/complicaciones , Dermatosis de la Mano/etiología , Adulto , Femenino , Humanos , Hiperpigmentación/complicaciones , Enfermedad Iatrogénica , Fallo Renal Crónico/complicaciones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA